Wang and colleagues reported no relationship between ASPH and tumor grade or patients’ survival, with the truncated, catalytically inactive form Humbug serving as a potential prognostic biomarker of stage II CRC [9]. The gene discussed is ASPH; the disease is colorectal carcinoma.